Amy Indorf, MD | |
1320 Mercy Dr Nw, Canton, OH 44708-2614 | |
(330) 580-4706 | |
(330) 580-4707 |
Full Name | Amy Indorf |
---|---|
Gender | Female |
Speciality | Internal Medicine - Infectious Disease |
Location | 1320 Mercy Dr Nw, Canton, Ohio |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033295951 | NPI | - | NPPES |
1902827876 | Other | GROUP NPI | |
2157366 | Other | OH | GROUP MEDICAID |
0997131 | Medicaid | OH | |
9303389 | Other | OH | GROUP MEDICARE - MPCC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | 35057637I (Ohio) | Primary |
Entity Name | Mercy Professional Care, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902827876 PECOS PAC ID: 7416857198 Enrollment ID: O20040109000676 |
News Archive
Uncovering the network of genes regulated by a crucial molecule involved in cancer called mTOR, which controls protein production inside cells, researchers at the University of California, San Francisco (UCSF) have discovered how a protein "master regulator" goes awry, leading to metastasis, the fatal step of cancer.
Adapting a traditional endless runner video game and using a raccoon as the protagonist, researchers from the Universidad Carlos III de Madrid (UC3M) and the Complutense University of Madrid (UCM, in its Spanish acronym), among other institutions, have developed a platform that allows the identification and evaluation of the degree of attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that the type 2 diabetes market in Mexico will grow to $1.22 billion in 2014. Drivers of this growth include increasing prevalent population, expanding medical insurance coverage as well as the launch and use of new drugs in the market.
Ludwig Cancer Research and the Cancer Research Institute announce the initiation of a clinical trial to evaluate the combination of ONCOS-102, an experimental anti-tumor virotherapy, with the checkpoint blockade antibody IMFINZI (durvalumab) for advanced ovarian and colorectal cancers.
Democratic presidential candidate and former Sen. John Edwards (N.C.) recently released a universal health care proposal that incorporates "the bad idea of raising taxes on employers and forcing individuals to purchase insurance," but before "others get carried away with this model, they should take a look at its most recent manifestation in Massachusetts," Sally Pipes, president and CEO of the Pacific Research Institute, writes in a Wall Street Journal opinion piece.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Amy Indorf, MD 1320 Mercy Dr Nw, Canton, OH 44708-2614 Ph: (330) 580-4706 | Amy Indorf, MD 1320 Mercy Dr Nw, Canton, OH 44708-2614 Ph: (330) 580-4706 |
News Archive
Uncovering the network of genes regulated by a crucial molecule involved in cancer called mTOR, which controls protein production inside cells, researchers at the University of California, San Francisco (UCSF) have discovered how a protein "master regulator" goes awry, leading to metastasis, the fatal step of cancer.
Adapting a traditional endless runner video game and using a raccoon as the protagonist, researchers from the Universidad Carlos III de Madrid (UC3M) and the Complutense University of Madrid (UCM, in its Spanish acronym), among other institutions, have developed a platform that allows the identification and evaluation of the degree of attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that the type 2 diabetes market in Mexico will grow to $1.22 billion in 2014. Drivers of this growth include increasing prevalent population, expanding medical insurance coverage as well as the launch and use of new drugs in the market.
Ludwig Cancer Research and the Cancer Research Institute announce the initiation of a clinical trial to evaluate the combination of ONCOS-102, an experimental anti-tumor virotherapy, with the checkpoint blockade antibody IMFINZI (durvalumab) for advanced ovarian and colorectal cancers.
Democratic presidential candidate and former Sen. John Edwards (N.C.) recently released a universal health care proposal that incorporates "the bad idea of raising taxes on employers and forcing individuals to purchase insurance," but before "others get carried away with this model, they should take a look at its most recent manifestation in Massachusetts," Sally Pipes, president and CEO of the Pacific Research Institute, writes in a Wall Street Journal opinion piece.
› Verified 4 days ago
Nishad Avinash Barve, Infectious Disease Medicare: Medicare Enrolled Practice Location: 1320 Mercy Dr Nw, Canton, OH 44708 Phone: 330-489-1000 | |
Todd L Johnson, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4466 Fulton Dr Nw, Canton, OH 44718 Phone: 330-489-1386 Fax: 330-489-1258 | |
John C Tsai, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4466 Fulton Dr Nw, Canton, OH 44718 Phone: 330-489-1386 Fax: 330-489-1258 | |
David Andrew Beard, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2600 6th St Sw, Canton, OH 44710 Phone: 330-363-2180 | |
Yara Khouri, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2600 Sixth St Sw, Canton, OH 44710 Phone: 330-363-6235 | |
Dr. Mitchell Haut, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1455 Harrison Ave Nw, Ste 105, Canton, OH 44708 Phone: 330-453-9993 Fax: 330-453-9996 | |
Ramana Podugu, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2600 6th St Sw, Suite A2-710, Canton, OH 44710 Phone: 330-454-8076 Fax: 330-454-3927 |